Log in

OTCMKTS:BVNRY - BAVARIAN NORDIC/S Stock Price, Forecast & News

$10.46
0.00 (0.00 %)
(As of 01/29/2020)
Add
Today's Range
$10.40
Now: $10.46
$10.46
50-Day Range
$8.25
MA: $9.38
$10.46
52-Week Range
$6.42
Now: $10.46
$10.93
Volume799 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bavarian Nordic A/S, a biotechnology company, develops, manufactures, and commercializes a portfolio of cancer immunotherapies and vaccines for infectious diseases. The company markets non-replicating smallpox vaccine under the IMVAMUNE and IMVANEX names. It is also developing MVA-BN RSV, which is in Phase II clinical trials development stage for the prevention of respiratory syncytial virus; MVA-BN Filo that is in Phase III clinical trials for the treatment of Ebola and Marburg; and MVA-BN HPV that is in Phase I/IIa clinical trials to treat human papillomavirus. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:BVNRY
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees419
Next Earnings Date3/19/2020 (Estimated)
OptionableNot Optionable

Receive BVNRY News and Ratings via Email

Sign-up to receive the latest news and ratings for BVNRY and its competitors with MarketBeat's FREE daily newsletter.


BAVARIAN NORDIC/S (OTCMKTS:BVNRY) Frequently Asked Questions

What is BAVARIAN NORDIC/S's stock symbol?

BAVARIAN NORDIC/S trades on the OTCMKTS under the ticker symbol "BVNRY."

When is BAVARIAN NORDIC/S's next earnings date?

BAVARIAN NORDIC/S is scheduled to release their next quarterly earnings announcement on Thursday, March 19th 2020. View Earnings Estimates for BAVARIAN NORDIC/S.

Has BAVARIAN NORDIC/S been receiving favorable news coverage?

News headlines about BVNRY stock have been trending negative this week, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. BAVARIAN NORDIC/S earned a news sentiment score of -2.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for BAVARIAN NORDIC/S.

What other stocks do shareholders of BAVARIAN NORDIC/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BAVARIAN NORDIC/S investors own include Genmab A/S (GNMSF), Centerstate Bank (CSFL), Denny's (DENN), Unity Biotechnology (UBX), Acceleron Pharma (XLRN), AC Immune (ACIU), Automatic Data Processing (ADP), Aimmune Therapeutics (AIMT), ArQule (ARQL) and BioCryst Pharmaceuticals (BCRX).

Who are BAVARIAN NORDIC/S's key executives?

BAVARIAN NORDIC/S's management team includes the folowing people:
  • Dr. Paul Chaplin, CEO & Pres (Age 52)
  • Mr. Henrik Juuel, CFO & Exec. VP (Age 54)
  • Mr. Henrik Birk, COO & Exec. VP (Age 45)
  • Dr. Tommi Kainu, Exec. VP & Chief Bus. Officer (Age 46)
  • Dr. Christopher R. Heery, Chief Medical Officer

How do I buy shares of BAVARIAN NORDIC/S?

Shares of BVNRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is BAVARIAN NORDIC/S's stock price today?

One share of BVNRY stock can currently be purchased for approximately $10.46.


MarketBeat Community Rating for BAVARIAN NORDIC/S (OTCMKTS BVNRY)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  175 (Vote Outperform)
Underperform Votes:  142 (Vote Underperform)
Total Votes:  317
MarketBeat's community ratings are surveys of what our community members think about BAVARIAN NORDIC/S and other stocks. Vote "Outperform" if you believe BVNRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BVNRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel